Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Purpose Diffuse malignant peritoneal mesothelioma (DMPM) is a rare primary peritoneal malignancy. Its prognosis has been improved by an aggressive locoregional treatment combining extensive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Prognostic factors are currently poorly defined for this disease but are essential if treatment is to be standardized.Methods Twenty-eight patients with DMPM, who were considered preoperatively to be candidates for CRS and HIPEC between June 1998 and August 2010 at our institution, were selected for this study. Medical records and histopathological features were retrospectively reviewed and 24 clinical, histological, and immunohistochemical parameters were assessed for their association with overall survival by univariate and multivariate analyses.Results The following factors were significantly associated with overall survival by univariate analysis: predominant histological growth pattern in the epithelioid areas, nuclear grooves in the epithelioid areas, atypical mitoses, and calretinin and GLUT1 expression by immunohistochemistry in the epithelioid areas. Expression of the facilitative glucose transporter protein GLUT1 in the epithelioid areas was the only factor independently associated with overall survival by multivariate analysis.Conclusions GLUT1 expression appears to be an indicator of poor prognosis in DMPM. Standard histological classification of DMPM may not be adequate to select patients for aggressive locoregional treatments, such as CRS and HIPEC. Multicenter validation of the prognostic factors identified in this preliminary study is needed to refine patient selection for potential cure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased levels of GLUT-1 are often correlated with poorer prognoses [117,118].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [118]
In the citing paper
“It was demonstrated by Minato et al. that mesothelioma cells can upregulate GLUT-1 to uptake glucose more efficiently.”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [118]
Citations
Cites
The control of the false discovery rate in multiple testing under dependency
Benjamini, Y., & Yekutieli, D. (2001) · The Annals of Statistics · doi:10.1214/aos/1013699998 · Cited by 10,490 · cited 1×
“Univariate analysis of survival was performed using Cox regression analysis with a correction for multiple comparisons using the B-Y method.(47) The significant prognostic variables identified by”
MethodClinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis
Jacquet, P., & Sugarbaker, P. H. (1996) · Cancer Treatment and Research · doi:10.1007/978-1-4613-1247-5_23 · Cited by 1,708 · cited 2×
“Completeness of cancer resection (CC-score) was assessed according to Jacquet and Sugarbaker’s criteria (Table 1).(45)”
MethodSugarbaker, P. H. (1995) · Annals of Surgery · doi:10.1097/00000658-199501000-00004 · Cited by 1,543
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229 · cited 2×
“Transport of glucose across the plasma membrane of mammalian cells is mediated by facilitative glucose transporters proteins (GLUTs), that function as energyindependent systems down a concentration gradient.(50)”
BackgroundYan, T. D., Deraco, M., Baratti, D., Kusamura, S., Elias, D., Glehen, O., Gilly, F. N., Levine, E. A., Shen, P., Mohamed, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9640 · Cited by 696
Self-citation(2012) · Hepatogastroenterology · doi:10.5754/hge12157 · Cited by 460
Feldman, A. L., Libutti, S. K., Pingpank, J. F., Bartlett, D. L., Beresnev, T. H., Mavroukakis, S. M., Steinberg, S. M., Liewehr, D. J., Kleiner, D. E., & Alexander, H. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.150 · Cited by 350
Yan, T. D., Welch, L., Black, D., & Sugarbaker, P. H. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl428 · Cited by 308 · cited 2×
“307 mm).(2) Atypical mitoses, intranuclear inclusions, and nuclear grooves were scored as present, if observed in any of the material.”
BackgroundKawamura, T., Kusakabe, T., Sugino, T., Watanabe, K., Fukuda, T., Nashimoto, A., Honma, K., & Suzuki, T. (2001) · Cancer · doi:10.1002/1097-0142(20010801)92:3<634::aid-cncr1364>3.0.co;2-x · Cited by 276
A review of peritoneal mesothelioma at the Washington Cancer Institute
Sugarbaker, P. H., Welch, L. S., Mohamed, F., & Glehen, O. (2003) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(03)00045-0 · Cited by 270
Self-citation
Research works printed but not linked: 1
- Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. World Health Organization Classification of Tumors: pathology and genetics of tumors of the lung, pleura, thymus and heart. 3rd ed. Lyon: IARC Press; 2004.
Cited by
Malignant peritoneal mesothelioma: a review
Kim, J., Bhagwandin, S., & Labow, D. M. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.03.96 · Cited by 190
“Individual studies have also identified sex, mitotic rate (58), GLUT-1 expression (82), and pre-operative CA125 (81) as predictors of survival.”
BackgroundSpiliotis, J. D., Halkia, E., & de Bree, E. (2016) · Current Oncology · doi:10.3747/co.23.2831 · Cited by 75
The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy
Chu, G. J., van Zandwijk, N., & Rasko, J. E. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01366 · Cited by 70
on behalf of the RENAPE Network, Villeneuve, L., Passot, G., Gléhen, O., Isaac, S., Bibeau, F., Rousset, P., & Gilly, F. N. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0571-y · Cited by 51
“The RENA-PATH Group also leads collaborative translational research projects based on the virtual biobank linked to the Registry clinical database [54, 55].”
MethodSelf-citationChen, X., Lü, P., Zhou, S., Zhang, L., Zhao, J., & Tang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14570 · Cited by 49
“Two [13, 17] of the studies used univariate analysis to assess the relationship between GLUT-1 and OS; however, they ignored other potential influencing factors.”
MethodResult
Metadata
- Authors
- Hommell-Fontaine, J., Isaac, S., Passot, G., Decullier, E., Traverse-Glehen, A., Cotte, E., You, B., Mohamed, F., Gilly, F. N., Glehen, O., & Berger, F.
- Affiliations
- Hospices Civils de Lyon (FR)
- Lyon 1 Université (FR)
- Basingstoke and North Hampshire Hospital (GB)
- Venue
- Annals of Surgical Oncology
- Published
- 2013-06-26
- Volume
- 20
- Issue
- 12
- Pages
- 3892-3898
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W2094770704
- Cited by
- 23
- References
- 51
- Citations by year
- 2026: 1 · 2023: 2 · 2022: 2 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 2 · 2014: 2
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-01-04)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Annals of Surgical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- diffuse malignant peritoneal mesothelioma, GLUT1 expression, prognostic factors, overall survival, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, calretinin, atypical mitoses, patient selection
- MeSH terms
- Mesothelioma, Malignant, Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Hyperthermia, Induced, Immunoenzyme Techniques, Lung Neoplasms, Male, Mesothelioma, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Chemotherapy, Cancer, Regional Perfusion, Peritoneal Neoplasms, Prognosis, Retrospective Studies, Biomarkers, Tumor, Survival Rate, Tissue Array Analysis, Glucose Transporter Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study. https://app.cochat.ai/papers/10.1245/s10434-013-3077-4
- The paper
- Hommell-Fontaine, J., Isaac, S., Passot, G., Decullier, E., Traverse-Glehen, A., Cotte, E., You, B., Mohamed, F., Gilly, F. N., Glehen, O., & Berger, F. (2013). Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-013-3077-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.